HIV-1 at the placenta: immune correlates of protection and i... : Current Opinion in Infectious
Diseases HIV-1 at the placenta: immune correlates of protection and infection : Current Opinion …

Mother-to-child (vertical) transmission of HIV–1 can occur before, during or after birth,
although the relative contribution of each of these routes remains poorly quantified|| 1–4 …

HIV infection in pregnant women is associated with altered immune responses in HIV-
infected women and their offspring with clinical consequences for pregnancy outcome and …

Women seropositive for human immunodeficiency virus type 1 (HIV-1) are at an increased
risk for a number of adverse perinatal outcomes. Although efforts to reduce mother-to-child …

recent advances and therapeutic interventions Page 1 Perinatal HIV-1 transmission: recent
advances and therapeutic interventions Yvonne J. Bryson Objectives: To review recent advances …

Infection with HIV destroys the immune system and causes acquired immunodeficiency
syndrome (AIDS). Death results from common bacterial or opportunistic infections that are …

The human placenta is relatively resistant to Human immunodeficiency virus 1 (HIV-1), but
obstetric complications associated with inflammatory processes, including chorioamnionitis …

Despite the wide availability of antiretroviral drugs, more than 250,000 infants are vertically
infected with HIV-1 annually, emphasizing the need for additional interventions to eliminate …

Infection with human immunodeficiency virus type 1 (HIV-1), if left untreated, eventually
leads to profound immunocompromise and death as host defenses are no longer able to …

Despite the widespread use of antiretrovirals (ARV), more than 150,000 pediatric HIV-1
infections continue to occur annually. Supplemental strategies are necessary to eliminate …